Farris Maryanne Maunsell

CIK: 0001950052

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)4 (57.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

HAE

HAEMONETICS CORP

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

HAE
HAEMONETICS CORP
Jun 5, 2026
Tax Payment(F)
Direct
259 shares at avg. $71.28$18K
HAE
HAEMONETICS CORP
May 15, 2026
Award(A)
Direct
2.2K shares-
HAE
HAEMONETICS CORP
May 15, 2026
Tax Payment(F)
Direct
197 shares at avg. $56.29$11K
HAE
HAEMONETICS CORP
Jun 5, 2025
Award(A)
Direct
2.7K shares-
HAE
HAEMONETICS CORP
May 16, 2025
Award(A)
Direct
800 shares-
HAE
HAEMONETICS CORP
May 16, 2025
Tax Payment(F)
Direct
68 shares at avg. $70.31$5K
HAE
HAEMONETICS CORP
May 15, 2025
Tax Payment(F)
Direct
60 shares at avg. $69.38$4K

		Type	Shares	Price		Ownership
Jun 5, 2026	HAE HAEMONETICS CORP	Tax Payment(F)	259	$71.28	$18,462	Direct
May 15, 2026	HAE HAEMONETICS CORP	Award(A)	2,220	-	$0	Direct
May 15, 2026	HAE HAEMONETICS CORP	Tax Payment(F)	197	$56.29	$11,089	Direct
Jun 5, 2025	HAE HAEMONETICS CORP	Award(A)	2,662	-	-	Direct
May 16, 2025	HAE HAEMONETICS CORP	Award(A)	800	-	-	Direct
May 16, 2025	HAE HAEMONETICS CORP	Tax Payment(F)	68	$70.31	$4,781	Direct
May 15, 2025	HAE HAEMONETICS CORP	Tax Payment(F)	60	$69.38	$4,163	Direct

1-7 of 7 transactions

About Maunsell Farris Maryanne

Maunsell Farris Maryanne (SEC CIK 0001950052) files insider reports with the SEC as VP, Chief Accounting Officer of HAEMONETICS CORP (HAE).

Signal8 holds 5 ownership filings by Maunsell Farris Maryanne, all Form 4s, filed between May 19, 2025 and Jun 8, 2026. Those filings report 7 transactions, from May 15, 2025 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Maunsell Farris Maryanne's filings is in BOSTON, MA.

Recent filings by Maunsell Farris Maryanne

Jun 5, 2026: Tax withholding of HAE shares (Form 4, code F).
May 15, 2026: Grant or award of HAE shares (Form 4, code A).
May 15, 2026: Tax withholding of HAE shares (Form 4, code F).
Jun 5, 2025: Grant or award of HAE shares (Form 4, code A).
May 16, 2025: Grant or award of HAE shares (Form 4, code A).

Other insiders filing for HAEMONETICS CORP (HAE)

Galvin Roy, EVP, Chief Commercial Officer
Madaus Martin D, Director
Zane Ellen M, Director
Pomeroy Claire, Director
KROLL MARK W, Director
Johnson Lloyd Emerson, Director

How to read Form 4 transaction codes